| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2001PNAS...9813954T |
| P356 | DOI | 10.1073/PNAS.231490898 |
| P932 | PMC publication ID | 61148 |
| P698 | PubMed publication ID | 11717452 |
| P5875 | ResearchGate publication ID | 235607550 |
| P2093 | author name string | J Yokota | |
| M I Lerman | |||
| B Gao | |||
| J D Minna | |||
| Y Sekido | |||
| M Kondo | |||
| H Drabkin | |||
| A F Gazdar | |||
| Y Tomizawa | |||
| J Roche | |||
| P2860 | cites work | An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo | Q41145880 |
| Alterations in DNA methylation: a fundamental aspect of neoplasia | Q41617101 | ||
| mab-20 encodes Semaphorin-2a and is required to prevent ectopic cell contacts during epidermal morphogenesis in Caenorhabditis elegans | Q47068958 | ||
| Semaphorins as mediators of neuronal apoptosis. | Q51088221 | ||
| Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia | Q56418625 | ||
| Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences | Q72845257 | ||
| Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung | Q73061212 | ||
| Semaphorin III can induce death in sensory neurons | Q73250608 | ||
| High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints | Q73679061 | ||
| Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display | Q78225854 | ||
| Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates | Q22010646 | ||
| Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression | Q24291194 | ||
| Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns | Q24311901 | ||
| Identification of semaphorin E as a non-MDR drug resistance gene of human cancers | Q24315145 | ||
| Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines | Q24318941 | ||
| Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer | Q24319164 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| High sensitivity mapping of methylated cytosines | Q24630600 | ||
| Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity | Q24677555 | ||
| Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration | Q24681536 | ||
| The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium | Q28138149 | ||
| Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression | Q28139015 | ||
| Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells | Q28209907 | ||
| Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity | Q28291642 | ||
| Semaphorins and their receptors in vertebrates and invertebrates | Q28611465 | ||
| Molecular basis of semaphorin-mediated axon guidance | Q28611466 | ||
| Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. | Q30884723 | ||
| Aberrant promoter methylation of multiple genes in non-small cell lung cancers. | Q31983232 | ||
| Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth | Q33783522 | ||
| Signalling by semaphorin receptors: cell guidance and beyond. | Q33994985 | ||
| Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa | Q35609257 | ||
| Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. | Q36382096 | ||
| Semaphorin 3A growth cone collapse requires a sequence homologous to tarantula hanatoxin | Q36679093 | ||
| NCI-Navy Medical Oncology Branch cell line data base | Q36819549 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| apoptotic process | Q14599311 | ||
| cell growth | Q189159 | ||
| P304 | page(s) | 13954-9 | |
| P577 | publication date | 2001-11-20 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B | |
| P478 | volume | 98 |
| Q36429393 | 3p21.3 tumor suppressor cluster: prospects for translational applications |
| Q36462168 | A knowledge framework for computational molecular-disease relationships in cancer |
| Q39643729 | A role for class 3 semaphorins in prostate cancer |
| Q39244694 | A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing |
| Q37412910 | Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma. |
| Q34518491 | BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization. |
| Q64276040 | Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression |
| Q34185287 | Collapsin response mediator protein-1: a novel invasion-suppressor gene |
| Q33337445 | CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future |
| Q37123409 | DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers |
| Q37113559 | DNA methylation in hepatocellular carcinoma |
| Q40660977 | Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer. |
| Q36706060 | Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer |
| Q35768271 | Distinguishing lung tumours from normal lung based on a small set of genes |
| Q34905803 | Elimination of aberrant DRG circuitries in Sema3A mutant mice leads to extensive neuronal deficits |
| Q64981530 | Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B). |
| Q38799612 | Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. |
| Q38844664 | Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers |
| Q24538785 | Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. |
| Q37407261 | Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis |
| Q34710709 | Focus on lung cancer |
| Q40595717 | Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. |
| Q38743861 | GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis |
| Q35791851 | Gene discovery in bladder cancer progression using cDNA microarrays |
| Q34963574 | Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. |
| Q42374239 | Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesis |
| Q33647661 | Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer |
| Q28941241 | Identification and characterization of a novel member of murine semaphorin family |
| Q79793020 | Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B |
| Q36624053 | Identification of potential therapeutic targets for lung cancer by bioinformatics analysis |
| Q40543079 | Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene |
| Q33972805 | Lung cancer * 9: Molecular biology of lung cancer: clinical implications |
| Q34053125 | Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. |
| Q36661538 | Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation |
| Q24610335 | Molecular biology of lung cancer: clinical implications |
| Q41692560 | Molecular profiling of the "plexinome" in melanoma and pancreatic cancer |
| Q38392559 | NRP-1 expression in bladder cancer and its implications for tumor progression |
| Q96304812 | NRP2 as an Emerging Angiogenic Player; Promoting Endothelial Cell Adhesion and Migration by Regulating Recycling of α5 Integrin |
| Q28295909 | Netrin-1 and its receptors in tumorigenesis |
| Q33957987 | Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells |
| Q38161356 | Neuropilins: a new target for cancer therapy |
| Q26998786 | Neuropilins: expression and roles in the epithelium |
| Q37892341 | Novel strategies for the treatment of small-cell lung carcinoma |
| Q60649889 | Null and conditionalsemaphorin 3B alleles using a flexiblepuro?tk loxP/FRT vector |
| Q36797506 | Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression |
| Q39266196 | Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells. |
| Q34110864 | Repeated small perturbation approach reveals transcriptomic steady states |
| Q35563102 | Search for unknown tumor‐antagonizing genes |
| Q24550871 | Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells |
| Q27306612 | Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model |
| Q24564247 | Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect |
| Q37383690 | Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells |
| Q36710174 | Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice |
| Q47724321 | Semaphorin 3F is critical for development of limbic system circuitry and is required in neurons for selective CNS axon guidance events. |
| Q24562741 | Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype |
| Q91596435 | Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells |
| Q24550908 | Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading |
| Q34768320 | Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion |
| Q35958869 | Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer |
| Q37426239 | Semaphorin signals on the road to cancer invasion and metastasis |
| Q36936042 | Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker? |
| Q31088312 | Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain |
| Q38804261 | Semaphorins and their Signaling Mechanisms |
| Q37034914 | Semaphorins and their receptors in immune cell interactions. |
| Q37072227 | Semaphorins and their receptors in lung cancer. |
| Q36325591 | Semaphorins command cells to move |
| Q35658200 | Semaphorins in angiogenesis and tumor progression |
| Q33372124 | Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells |
| Q36193422 | The brain within the tumor: new roles for axon guidance molecules in cancers. |
| Q38256958 | The emerging role of class-3 semaphorins and their neuropilin receptors in oncology |
| Q59792649 | The extracellular SEMA domain attenuates intracellular apoptotic signaling of semaphorin 6A in lung cancer cells |
| Q27641965 | The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D |
| Q39137754 | The role of axon guidance factor semaphorin 6B in the invasion and metastasis of gastric cancer |
| Q36289377 | The role of semaphorins and their receptors in gliomas |
| Q38082866 | The role of semaphorins and their receptors in vascular development and cancer. |
| Q38929961 | The role of the semaphorins in cancer |
| Q35012897 | The semaphorins |
| Q37200576 | The semaphorins: versatile regulators of tumour progression and tumour angiogenesis |
| Q36640026 | The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment |
| Q35732885 | To move or not to move? Semaphorin signalling in cell migration |
| Q35593032 | Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers |
| Q34935968 | Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers |
| Q24317695 | WNT7a induces E-cadherin in lung cancer cells |
| Q36092830 | p53, apoptosis and axon-guidance molecules |
Search more.